
--- Page 1 ---
FINAL DIAGNOSIS: Part 1: Breast. Right, Segmental mastectomy - Invasive Ductal Carcinoma,nos type, poorLy Differentiated. B.  THe INVASiVE TUmOr MEASURES 2.0 Cm IN GREATESt DImeNSiON.nOTTINGhAm GRADE 3 (TUBULE FORmAtiON 3, NUClEAR PLeOmORphiSm 3, mITOtIC ACtivIty 3; tOTAL SCORE 9/9). C.  DUctAL CArcinOmA IN-SitU (DCIS), nUCLEAR GRADE 3, micROPaPILLARy AND PAPILLARy TYpeS WITH COMEDONECROSIS; CONSTITUTES 60% OF THE TOTAL TUMOR MASS AND IS PRESENT ADMIXED WITH AND AWAY FROM THE INVASIVE COMPONENT. D. LYMPH VASCULAR SPACE INVASION IS IDENTIFIED. E. RESECTION MARGINS ARE NEGATIVE fOR CARCINOMA, HOWEVER THE INVASIVE CARCINOMA EXTENDS TO 0.5 CM FROM THE ANTERIOR MARGIN.DUCTAL CARCINOMA IN-SITU EXTENDS TO <0.1 CM FROM THE LATeral mArgin AnD 0.2 Cm FrOm the AnTerIOR mARgin. F. SKIN IS NEGATIVE FOR TUMOR FIBrOcySTIC ChAnges WIth DuCtAl EPITheLiAl hypeRpLASIA, PReVIOUS bIOpSy SiTe ChAnGES. G. H. THe INVASIVe TumOR CeLLS ArE POsITIVe fOR eSTROgen AND PROgESTErOne ReCepTORS AND NEGATIVE fOR HER-2 (1+), AS PER PREVIOUS PATHOLOgY REPORT Part 2: breast, right, new deep margin, Segmental mastectomy - A.  NO CARCINOMA IDENTIFIED. B.  FiBROcySTiC ChAngES WIth DUctal EpiTHeLiAL hypERpLASiA,COLumnAR CeLl CHanGE. PART 3: Lymph NODE, RIgHT AXILLA, SEnTINeL #1, BIOPSY -- One Lymph nODe, nEgaTivE fOR metAStaTIC CARcInOmA (0/1). CASE SYNOPSIS: SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST 1cs-0-3 LATERALITy: PROCEDURE: Right Segmental Sihs, brust, Nos LOCATION: C50.9 3|13/11 h SIZE OF TUMOR: Not specified MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: Maximum dimension invasive component: 2 cm TUMOR TYPE (invasive component): No NOTTINGHAM SCORE: Ductal adenocarcinoma, NOS Nuclear grade: 3 Tubule formation: 3 Mitotic activity score: 3 Tota! Nottingham score: 9 ANGIOLYMPHATIC INVASION: Nottingham grade (1, 2, 3): 3 Yes DERMAL LYMPHATIC INVASION:S CALCIFICATION: No TumOr type, In SItu: Yes, malignant zones  Papillary  Micropapillary DCIS admixed and outside of invasive carcinoma component SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT: Percent of tumor occupied by in situ component: 60 % No SURG MARGINS INVOLVED BY IN SITU COMPONENT: Distance of invasive tumor to closest margin: 5 mm No Distance of in situ disease to closest margin: 1 mm LYMPH NODES POSITIVE: LYMPH NODES EXAMINED: 0 METHOD(S) OF LYMPH NODE EXAMINATION: 1 SENTINEL NODE METASTASIS:  H/E stain UUID:1F35A542-2795-4B1F-A846-7097B442C2D9 TCgA-BH-A0hU-01A-PR  No Redacted ONLY KERATIN POSITIVE CELLS ARE PRESENT: SKIN INVOLVED (ULCERATION): No No NON-NEOPLASTiC BREAST TISSUE: FCD, Other: columnar cell change t Stage, pathologIC: N stage, pathologiC: pT1c pNO M STAgE, PAThOLOGIC: ESTROGEN RECEPTORS: pMX PROGESTERONE RECEPTORS: positive HER2/NEU:  positive zero or 1+ 3/131 #